Abstract | OBJECTIVE: n-3 Polyunsaturated fatty acids (PUFAs) supplementation reduces systemic inflammation and improves renal and cardiovascular prognosis in kidney transplant recipients. However, patient compliance is poor because bad-tasting fish oils are used as an n-3 PUFA source. Therefore, we explored whether the beneficial effects of n-3 can be obtained by administering a diet based on n-3-rich foods. METHODS: Sixty kidney transplant recipients were assigned to 2 different groups: the CON group (n = 28), which continued with their usual diet, and the DIET group (n = 32), which followed an n-3-rich diet for 6 months. Twenty-six patients in the DIET group and 24 in the CON group completed the study. End points of the study were changes in n-3 PUFAs intake, n-6:n-3 PUFAs ratio, systemic inflammation markers, and renal function during the 6 months of the dietary treatment. RESULTS: Three and 6 months after the beginning of the study, n-3 PUFA intake was significantly higher and the n-6: n-3 PUFA ratio was markedly lower than baseline in the DIET group. Plasma total cholesterol, triglycerides, C-reactive protein, and interleukin (IL)-6 decreased as well. IL-6 mRNA levels in peripheral blood mononuclear cells were also lower than at the beginning of the study. Proteinuria and microalbuminuria were reduced by 50% with respect to the baseline, whereas glomerular filtration rate (GFR) was unchanged. No change in the aforementioned parameters was observed in the CON group throughout the study. CONCLUSION:
|
Authors | Massimo Sabbatini, Luca Apicella, Mauro Cataldi, Immacolata Maresca, Annamaria Nastasi, Sossio Vitale, Bruno Memoli, Loredana Postiglione, Eleonora Riccio, Riccardo Gallo, Stefano Federico, Bruna Guida |
Journal | Journal of the American College of Nutrition
(J Am Coll Nutr)
Vol. 32
Issue 6
Pg. 375-83
( 2013)
ISSN: 1541-1087 [Electronic] United States |
PMID | 24606710
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Biomarkers
- Fatty Acids, Unsaturated
- Immunosuppressive Agents
- Interleukin-6
- Lipids
- C-Reactive Protein
|
Topics |
- Adult
- Biomarkers
(blood)
- C-Reactive Protein
(metabolism)
- Diet
- Fatty Acids, Unsaturated
(administration & dosage)
- Female
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Inflammation
(diet therapy, drug therapy)
- Interleukin-6
(blood)
- Kidney Transplantation
- Lipids
(blood)
- Male
- Middle Aged
- Prognosis
- Treatment Outcome
|